Deciphering Clonal Evolution and Dissemination of Multiple Myeloma Cells In Vivo
نویسندگان
چکیده
منابع مشابه
Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
Clonal heterogeneity and clonal evolution have emerged as critical concepts in the field of oncology over the past four decades, largely thanks to the implementation of novel technologies such as comparative genomic hybridization, whole genome/exome sequencing and epigenetic analysis. Along with the identification of cancer stem cells in the majority of neoplasia, the recognition of intertumor ...
متن کاملTreatment of Multiple Myeloma
Les traitements classiques de myelome multiple et les schemas differents proposes ont ete mis en revue. La poly chimiotherapie de la maladie avec une com-binaison de cyclophosphamide, B.C.N.U. Alkeran, Perdnisone et Vincristine a donnee une meilleur Resultat ceci surtout dans les formes graves et rapidement progressive de la maladie. D'autres sehemas therapeutiques sont en cours.
متن کاملClonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia.
Patients with paraproteinemia have abnormalities in their T-cell subsets including inversion of the CD4:CD8 ratio and increased expression of activation markers. Recently, distortions in T-cell receptor (TCR) TCRAV and TCRBV gene segment expression have been reported, although the significance of these observations is unclear given the finding of clonal populations of CD8+ T cells in healthy el...
متن کاملMultiple Myeloma Update
This literature review presents the most recent developments in the management of multiple myeloma, which is characterized by the presence of abnormal plasma cells (myeloma cells) that accumulate into the bone marrow. Aspects related to pathophysiology, clinical manifestations, laboratory, study and treatment are described. These pieces of information are necessary to accomplish a better ...
متن کاملSpatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition.
Recent reports on the genetic landscape of the plasma cell malignancy, multiple myeloma (MM), have revealed potential therapeutic targets such as activating mutations in BRAF kinase in subsets of patients. However, assuming suitable targeted therapies become available, clonal evolution and widespread intraclonal heterogeneity in MMwill pose a challenge to their routine clinical use. Wewere thef...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2018
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2018-99-113916